Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Attard, GerhardtSydes, Matthew R.
Mason, Malcolm D.
Clarke, Noel W.
Aebersold, Daniel M
de Bono, Johann S.
Dearnaley, David P.
Parker, Chris C.
Ritchie, Alastair W.S.
Russell, J. Martin
Thalmann, George
Cassoly, Estelle
Millman, Robin
Matheson, David
Schiavone, Francesca
Spears, Melissa R.
Parmar, Mahesh K.B.
James, Nicholas D.
Issue Date
2014-11
Metadata
Show full item recordCitation
Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial 2014, 66 (5):799 European UrologyJournal
European UrologyAdditional Links
http://linkinghub.elsevier.com/retrieve/pii/S030228381400520XType
Journal articleLanguage
enDescription
ClinicalTrials.gov identifier NCT00268476ISSN
03022838Sponsors
The Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.ae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2014.05.038